Purchase Order FA460022P0015
- Not listed
- This is a firm fixed-price purchase order awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Beckman Coulter, Inc. for a microbiology analyzer at a total potential value of $137,031.84. The contract has no set-aside designation. Beckman Coulter, Inc. is a subsidiary of Danaher Corporation, which has a history of providing clinical laboratory equipment, reagents, and services to federal agencies including the Department of Veterans Affairs and Defense Health Agency. This...
- This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Beckman Coulter, Inc., a manufacturer of biomedical testing equipment, laboratory instruments, and related services. The contract is for the provision of DXH 800 Analyzer Systems, with a ceiling value of $43,131.52 and a period of performance ending on May 31, 2024. The contract was not set aside for any specific business type. Beckman Coulter, Inc., a subsidiary of Danaher Corporation, is a global...
- This contract was awarded by the Defense Health Agency (DHA) to Beckman Coulter, Inc., a subsidiary of Danaher Corporation, to provide microbiology tests. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has a potential value of $205,747.50 through the completion date of September 30, 2023. Beckman Coulter is a manufacturer of clinical laboratory equipment, reagents, and services, and has previously held contracts with the Department of Veterans Affairs and...
- This is a firm fixed-price delivery order awarded by the Department of the Navy Bureau of Medicine and Surgery to Beckman Coulter, Inc. for $116,119.02 worth of microscopy analyzer tests. The contract has a completion date of September 30, 2018. Beckman Coulter, Inc. is a subsidiary of Danaher Corporation that provides clinical laboratory equipment, reagents, and services. The company has previously held federal contracts with the Department of Veterans Affairs, Defense Health Agency, and...
- The Defense Health Agency awarded a $722,433 firm fixed-price purchase order to Beckman Coulter, Inc. (US Customer Operations division) for microbiology automated specimen analyzers. The contract was awarded on October 1, 2021, with an ultimate completion date of September 30, 2026, and will be performed at Fort Moore, Georgia. This award stems from a Department of the Army Medical Command solicitation issued in September 2021 seeking to lease two DxM Walkaway 96 AST (antibiotic susceptibility...
- The Defense Health Agency awarded a delivery order to Beckman Coulter, Inc. valued at $213,686.60 on October 1, 2024, for microscopy and chemistry testing services on a cost-per-reportable-result (CPRR) basis. This delivery order, which extends through September 30, 2029, will be performed at Beckman Coulter's facility in Columbia, South Carolina, and represents work under the Critical Analyzers, Laboratory (FSS-66-III) Federal Supply Schedule. The award was made through competitive...
- This is a $33,142.98 firm fixed price purchase order awarded by the Defense Health Agency to Beckman Coulter, Inc., a subsidiary of Danaher Corporation. The contract is for the delivery of short-term clinical chemistry and hematology testing equipment and services. Beckman Coulter is a provider of clinical laboratory equipment, reagents, and services. The company has a history of supplying testing equipment, consumables, and support to the Department of Veterans Affairs and Department of...
- This is a $379,924.67 firm-fixed-price definitive contract awarded by the Air Mobility Command (AMC) to Beckman Coulter, Inc., a subsidiary of Danaher Corporation, for a Microbiology Identification and Susceptibility Analyzer and Reagents. The contract has a completion date of September 30, 2021 and was awarded on March 31, 2016. This award was not set aside for small businesses. Beckman Coulter is a global manufacturer of biomedical testing equipment, laboratory instruments, reagents, software,...
- This $24,475.74 firm fixed-price purchase order was awarded to Beckman Coulter, Inc., a subsidiary of Danaher Corporation, by the Defense Health Agency. The contract is for the provision of IQ200 clinical laboratory equipment, which includes automated diagnostic instrumentation, reagents, maintenance, training, and cost-per-reportable-result services. This contract was not set aside for any specific business category. Beckman Coulter is a prominent manufacturer of medical diagnostic technologies...
- Beckman Coulter, Inc. received a $550,348 firm fixed-price delivery order from the Defense Health Agency for microbiology cost-per-test services utilizing the MicroScan WalkAway platform. The contract, awarded June 1, 2025, with performance at the company's Brea, California facility, extends through May 31, 2030. This delivery order is issued under the Critical Analyzers, Laboratory (FSS-66-III) Federal Supply Schedule, a General Services Administration vehicle that streamlines procurement of...
This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Beckman Coulter, Inc., a global manufacturer of biomedical testing equipment and laboratory instruments. The contract is for the lease and maintenance of a microbiology identification and susceptibility analyzer, valued at $267,533.64, with a period of performance through December 13, 2027. The contract does not have a set-aside designation. Beckman Coulter, a subsidiary of Danaher Corporation, is an established provider of advanced scientific technologies and laboratory solutions to federal agencies, including the Department of Defense, Department of Veterans Affairs, and Centers for Disease Control and Prevention. This award demonstrates the company's capabilities in delivering specialized scientific instrumentation and related maintenance services to support the DHA's biomedical research and healthcare initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Exercise an Option | $24.3k | 5/8/25 | |
| P00003 | Other Administrative Action | $0 | 4/29/25 | |
| P00002 | Exercise an Option | $24.3k | 5/7/24 | |
| P00001 | Exercise an Option | $24.3k | 5/10/23 | |
| Not listed | Not listed | $24.3k | 5/10/22 |